Medicare rolls out $50 GLP-1 drugs. ‘Pandemonium’ ahead for Michigan doctors?

The new Medicare program provides a temporary discount for GLP-1 drugs, which are used for weight loss, at just $50 per month, sparking excitement among some beneficiaries but also concerns among Michigan doctors about potential disruptions in care. The program's limited eligibility could exclude many patients, leading to worries about access and follow-up care. This initiative highlights the ongoing challenges in making effective treatments more affordable while navigating the complexities of healthcare policy and patient needs.